Elderly Patients With Diabetes: Special Aspects to Consider

Kontinuierliches Glukosemonitoring im Erleben des individuellen Patienten

Patientensysteme zum kontinuierlichen Glukosemonitoring (CGM) liefern den Patienten wertvolle Information uber Glukoseverlaufe und -trends und haben prinzipiell das Potenzial, die Diabetes(selbst)behandlung deutlich zu verbessern. Zahlreiche empirische Befunde aus klinischen Studien belegen die Effektivitat von CGM. Allerdings zeigt sich auch, dass die Effektivitat von Patient zu Patient stark variieren kann und nicht alle Patienten die Informationen, die CGM liefert, optimal fur die Diabetesbehandlung nutzen. Ausgehend von einem systematischen Uberblick uber die bestehende Befundlage, werden in diesem Beitrag psychosoziale und Verhaltensfaktoren diskutiert, die mit beeinflussen konnen, ob …

PsychDT Working Group

Background: Diabetes technology is a cornerstone of diabetes management in the 21st century, with advances in available devices over recent years playing a central role in the way that health care has progressed. Psychosocial interventions have been shown to have a positive impact on glycemic control, reduce psychological distress and reduce costs of health care. Addressing and improving psychosocial outcomes that complement biomedical improvements and looking to the future are crucial to enhance patient acceptance of artificial pancreas (AP) systems. Methods: To achieve closer collaboration and comparability across different AP research trials, a working group was established. Results: Exi…

Psychosocial Aspects of Continuous Glucose Monitoring

Continuous glucose monitoring (CGM) systems provide people with diabetes with valuable real-time information on glucose trajectories and trends, thus offering opportunities for improving diabetes self-management. Ample evidence from clinical trials underscores CGM effectiveness for biomedical outcomes including HbA1C and hypoglycemia. However, interindividual variability in CGM uptake seems to be substantial: Neither do all individuals with diabetes adopt CGM readily in their diabetes self-management, nor do all of them benefit from CGM. In this article, we focus on CGM effects on quality of life and the potential role of psychosocial patient characteristics for determining the uptake and …

40(th) EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004

Wünsche, Sorgen und Bedürfnisse bezüglich der Insulinpumpentherapie im Alter: Ergebnisse einer Befragung bei Menschen mit Typ-1-Diabetes mellitus im höheren Lebensalter und von Diabetesfachkräften

Zusammenfassung Hintergrund Mehr als die Hälfte aller Menschen mit Diabetes in Deutschland ist älter als 65 Jahre. Für eine erfolgreiche Insulinpumpentherapie (Continuous Subcutaneous Insulin Infusion; CSII) im hohen Erwachsenenalter sind Wünsche, Sorgen und Erfahrungen älterer Menschen mit Typ-1-Diabetes, erlebte Barrieren und förderliche Bedingungen von zentraler Bedeutung. Methodik Ältere Menschen mit Typ-1-Diabetes, die sich mit einer CSII behandeln (n = 136), sowie Fachkräfte aus dem Diabetesbereich (Diabetes Health Care Professionals; HCP; n = 96) nahmen an einem Fragebogensurvey teil, in dem anhand zweier offener Fragen Wünsche, Sorgen und Erfahrungen älterer Menschen mit Typ-1-Diabe…

Comment on Umpierrez and Klonoff. Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital. Diabetes Care 2018;41:1579–1589

We applaud Umpierrez and Klonoff (1) for reviewing the evidence on the application of insulin pump therapy (continuous subcutaneous glucose infusion [CSII]) and continuous glucose monitoring in inpatient settings. However, we missed a dedicated section about the patients’ perspective and experiences concerning insulin pump use in hospitals. In a qualitative survey conducted in Germany, elderly patients with type 1 diabetes (≥65 years, n = 136) and health care professionals (HCP, n = 96) were asked about their wishes, concerns, and needs related to CSII (2). The 290 responses (165 patients; 125 HCPs) were classified into three categories. First were positive experiences (patients n = 17; HCP…

Patient-Reported Outcomes and Continuous Glucose Monitoring: Can We Do Better With Artificial Pancreas Devices?

Patient-reported outcomes (PROs) assess a person’s experience, feelings, and thoughts about both their condition and its treatment. PROs are able to contribute to a benefit assessment of new medical products by introducing the patients’ subjective evaluation of medical products into the evaluation process. Thus, PROs are also the cornerstone of medical product development for understanding patients’ perceptions on medical products and/or its benefit assessment. In the past 15 years, PROs were also evaluated in most clinical trials performed with continuous glucose monitoring systems. However, in its recent evaluation of such trials, the German Institute for Quality and Efficiency in Health …